Safety and Efficacy of Re-irradiation With Carbon-ion Radiotherapy for Pelvic Recurrence of Rectal Cancer After Preoperative Chemoradiotherapy: A Retrospective Analysis
Authors:
Open Access
- 3 September 2022
- journal article
- research article
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 36 (5) , 2473-2480
Abstract
Background/Aim: Previous evaluation of the safety and clinical efficacy of re-irradiation for pelvic recurrence of rectal cancer after preoperative chemoradiotherapy (PCRT) and rectal surgery is insufficient. We evaluated the safety and efficacy of re-irradiation with carbon-ion radiotherapy (C-ion RT) for pelvic recurrence of rectal cancer after PCRT. Patients and Methods: We reviewed the medical records of patients treated with C-ion RT between August 2011 and December 2021 and analyzed the data of seven consecutive patients. The probabilities of overall survival (OS), local control (LC), and progression-free survival (PFS) were calculated using the Kaplan-Meier method. Toxicities were classified using the National Cancer Institute’s Common Terminology Criteria for Adverse Events (version 4.0). Results: The median follow-up duration after C-ion RT initiation was 30.9 months. Five patients received 73.6 Gy [relative biological effectiveness (RBE)] in 16 fractions, and two patients received 57.6 Gy (RBE) in 12 fractions. All patients completed C-ion RT as scheduled. Two-year estimated OS, LC, and PFS rates after C-ion RT initiation were 100%, 83.3%, and 28.6%, respectively. No patients developed grade ≥3 acute toxicity. Regarding late toxicities, one patient who received Gore-Tex sheets as a spacer before C-ion RT developed grade 3 colon perforation, and then developed a grade 3 urinary tract disorder. One patient developed grade 2 peripheral neuropathy. Conclusion: C-Ion RT showed favorable local efficacy with minimal toxicity. C-Ion RT might be an effective treatment option for pelvic recurrence of rectal cancer after PCRT even when re-irradiation of the pelvis is required.Keywords
This publication has 26 references indexed in Scilit:
- Carbon-Ion Radiation Therapy for Pelvic Recurrence of Rectal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerCochrane Database of Systematic Reviews, 2013
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trialThe Lancet Oncology, 2011
- Dose calculation algorithm of fast fine-heterogeneity correction for heavy charged particle radiotherapyPhysica Medica, 2011
- Stereotactic body radiotherapy for the treatment of presacral recurrences from rectal cancersJournal of Cancer Research and Therapeutics, 2011
- Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefitJournal of Surgical Oncology, 2009
- Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203Journal of Clinical Oncology, 2006
- Chemotherapy with Preoperative Radiotherapy in Rectal CancerNew England Journal of Medicine, 2006
- Carbon Beam Therapy Overcomes the Radiation Resistance of Uterine Cervical Cancer Originating from HypoxiaClinical Cancer Research, 2006
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001